Innova Captab Limited (BOM:544067)

Market Cap	40.31B -10.7%
Revenue (ttm)	14.97B +25.6%
Net Income	1.32B +3.9%
EPS	23.13 -8.2%
Shares Out	n/a
PE Ratio	30.44
Forward PE	22.82
Dividend	2.00 (0.28%)
Ex-Dividend Date	Jan 30, 2026

Volume	491
Average Volume	1,546
Open	701.80
Previous Close	703.60
Day's Range	688.00 - 712.50
52-Week Range	608.25 - 1,002.95
Beta	n/a
RSI	53.64
Earnings Date	May 21, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 1,600
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544067

Financial Performance

In fiscal year 2025, Innova Captab's revenue was 12.44 billion, an increase of 15.02% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.